RecruitingNCT00001975

Study of Skin Tumors in Tuberous Sclerosis

Cutaneous Tumorigenesis in Patients With Tuberous Sclerosis


Sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Enrollment

400 participants

Start Date

Jan 26, 2000

Study Type

OBSERVATIONAL

Conditions

Summary

Tuberous sclerosis is a rare, hereditary disease in which patients develop multiple tumors. Although not cancerous, the tumors can affect various organs, including the heart, lungs, kidneys, skin, and central nervous system, with serious medical consequences. The severity of disease varies greatly among patients, from barely detectable to fatal. This study will investigate what causes skin tumors to develop in patients with this disease. Patients with tuberous sclerosis 18 years and older may enroll in this study. Participants will undergo a medical history and thorough skin examination by a dermatologist. Those with skin tumors will be asked to undergo biopsy (tissue removal) of up to eight lesions, under a local anesthetic, for research purposes. The biopsies will all be done the same day. The tissue samples will be used for: examination of genetic changes, measurement of certain proteins and other substances, and growing in culture to study the genetics of tuberous sclerosis. ...


Eligibility

Min Age: 18 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This study is examining skin growths (tumors) in people with tuberous sclerosis complex (TSC) — a genetic condition that causes non-cancerous tumors to grow in the skin and other organs. **You may be eligible if...** - You have a diagnosis (definite, probable, or possible) of tuberous sclerosis complex (TSC) based on clinical or genetic criteria - You are between 18 and 90 years of age **You may NOT be eligible if...** - You are unable to give informed consent - You have a tendency to form thick, raised scars (keloids) - You are allergic to anesthetics - You have a bleeding disorder Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

National Institutes of Health Clinical Center

Bethesda, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT00001975


Related Trials